BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
Clinical trial NCT01562028 · COMPLETED
Trial details
- NCT number
- NCT01562028
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2018-10-31
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.